EUVIMEDEUVIMED entdecken
Open Access

BCOR loss promotes both retinoblastoma growth and susceptibility to IGF1R inhibition

Su-Chan Lee iD, Satoshi Nakata, Lujain Alaali, Kaixuan Wang, Pei-Chi Tsai, Khoa Pham, Brent A Orr, Quynh T Tran, Laura Asnaghi, Eric Raabe iD, Charles G Eberhart

Neuro-Oncology · 2025

DOI: 10.1093/neuonc/noaf096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Su-Chan Lee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Retinoblastoma, Proto-Oncogene Proteins, Repressor Proteins, Receptor, IGF Type 1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Children's Cancer Foundation, Children’s Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

BCL-6 corepressor (BCOR) loss-of-function alterations are common in clinically aggressive retinoblastoma. The study aim was to determine if BCOR loss promotes the growth and dissemination of retinoblastoma cells, and identify the pathways it regulates in these retinal tumors of childhood.

Methods

Gain- and loss-of-function strategies were used to modulate BCOR levels in a panel of retinoblastoma cell lines, and the effects on proliferation, clonogenicity, apoptosis, and migration were assessed in vitro and in murine xenograft models.

Results

BCOR knockdown or knockout in retinoblastoma lines with high protein levels increased tumor growth, invasion, clonogenicity, and chemoresistance in vitro, while increased expression in low BCOR lines slowed growth. Growth of retinoblastoma xenografts was similarly sensitive to BCOR gain or loss. BCOR reduction resulted in upregulation of IGF1 and activation of IGF1 receptor (IGF1R) signaling, and the effects of IGF1R inhibition were dependent on BCOR level. In vitro, reduction of retinoblastoma growth and induction of apoptosis by the IGF1R inhibitors linsitinib and AEW541 were also significantly stronger in cells with low BCOR as compared to controls. Both linsitinib and AEW541 suppressed colony formation in a dose-dependent manner in BCOR knockout or knockdown cells. Finally, high BCOR levels rendered retinoblastoma xenografts insensitive to linsitinib.

Conclusions

Loss of BCOR function is associated with more aggressive retinoblastoma cell line growth and chemoresistance, at least in part due to increased IGF1R signaling. Inhibiting IGF1R pharmacologically had a marked anti-tumor effect in aggressive retinoblastoma lacking BCOR, suggesting it as a new therapeutic target, although this still needs to be confirmed in clinical samples with BCOR mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RetinoblastomaProto-Oncogene ProteinsRepressor ProteinsReceptor, IGF Type 1Retinal NeoplasmsHumansAnimalsCell ProliferationMiceApoptosisXenograft Model Antitumor AssaysTumor Cells, CulturedCell Line, TumorCell MovementSignal TransductionDrug Resistance, Neoplasm

Stichwörter der Autor:innen

BCORIGF1IGF1Rretinoblastoma

Substanzen

Proto-Oncogene ProteinsRepressor ProteinsBCOR protein, humanIGF1R protein, humanReceptor, IGF Type 1

Autor:innen und Institutionen

  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Neurosurgery, Gunma University, Maebashi, Japan.
  • Department of Biochemistry and Molecular Biology, Johns Hopkins University School of Public Health, Baltimore, Maryland, USA.
  • Department of Pathology, St. Jude Children's Hospital, Memphis, Tennessee, USA.
  • Division of Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Su-Chan Lee, Eric Raabe

Förderung

  • Children's Cancer Foundation
  • Children’s Cancer Foundation

Zitieren

APA

Lee, S. C., Nakata, S., Alaali, L., Wang, K., Tsai, P. C., Pham, K., Orr, B. A., Tran, Q. T., Asnaghi, L., Raabe, E., & Eberhart, C. G. (2025). BCOR loss promotes both retinoblastoma growth and susceptibility to IGF1R inhibition. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf096

Vancouver

Lee SC, Nakata S, Alaali L, Wang K, Tsai PC, Pham K, et al. BCOR loss promotes both retinoblastoma growth and susceptibility to IGF1R inhibition. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf096

BibTeX
@article{Lee2025,
  author = {Lee, Su-Chan and Nakata, Satoshi and Alaali, Lujain and Wang, Kaixuan and Tsai, Pei-Chi and Pham, Khoa and Orr, Brent A and Tran, Quynh T and Asnaghi, Laura and Raabe, Eric and Eberhart, Charles G},
  title = {BCOR loss promotes both retinoblastoma growth and susceptibility to IGF1R inhibition},
  journal = {Neuro-Oncology},
  year = {2025},
  doi = {10.1093/neuonc/noaf096}
}
Kostenlos starten →